ROX index and predictors of failure to high-flow nasal prongs in COVID-19 patients and resistant hypoxemia. Med Int Méx 2023; 39 (3): 423-429. https://doi.org/10.24245/mim.v39i3.7711 Luis Alberto Revuelta-Rodríguez,1 Dulce María Dector-Lira2 1 Terapia Intermedia. 2 Jefatura…
Poisoning from disinfectant and cleaning products. Med Int Méx 2023; 39 (2): 322-328. https://doi.org/10.24245/mim.v39i2.5889 Leslie Moranchel-García,1 Luis Francisco Pineda-Galindo2 1 Internista, alta especialidad en Toxicología Clínica, Centro Toxicológico, Hospital Ángeles Lomas, Grupo Ángeles Servicios…
Angiotensin II in vasodilatory shock: the fourth musketeer. Med Int Méx 2023; 39 (2): 301-312. https://doi.org/10.24245/mim.v39i2.5516 Raul Carrillo-Esper,1 Karen Itzel González-Martínez,2 Roberto Emmanuel Islas-Ávila,2 Saul Salas-Zurita2 1 Jefe de División de Áreas Críticas. Profesor titular del…
COVID-19, experience in a severe burns center. Med Int Méx 2023; 39 (2): 266-272. https://doi.org/10.24245/mim.v39i2.7686 Martín J Sánchez-Zúñiga,1 Marco A Garnica-Escamilla,2 Alejandra Tamez-Coyotzin2 1 Jefe de servicio. 2 Médico adscrito. Unidad de Agudos y Choque adultos,…
Seroprevalence of SARS-CoV-2 and factors related in a population affiliated with a private health insurer in Bogotá, Colombia. Med Int Méx 2023; 39 (2): 243-250. https://doi.org/10.24245/mim.v39i2.7568 Mauricio Serra-Tamayo,1 Milcíades Ibañez-Pinilla,2 Víctor Alexander Saenz,1 Laura Forero,1 Jorge…
Correlation between ventilation perfusion PaO2/FiO2 ratio and SpO2/FiO2 ratio in hospitalized adult COVID-19 patients. Med Int Méx 2023; 39 (2): 227-234. https://doi.org/10.24245/mim.v39i2.7475 Idalid Itzel Mendoza-Morimoto, Rocío Milagro López-López Servicio de Medicina Interna, Hospital de…
Omicron variant and the immune scape. Med Int Méx 2023; 39 (1): 167-169. https://doi.org/10.24245/mim.v39i1.7965 Alfredo Cabrera-Rayo Internista-intensivista. Coordinador auxiliar de investigación en salud, IMSS. Resumen La incidencia de la variante ómicron del…
Tocilizumab, a cutting-edge therapeutic resource against SARS-CoV-2 infection: A scoping review. Med Int Méx 2023; 39 (1): 66-90. https://doi.org/10.24245/mim.v39i1.7847 Eduardo Tuta-Quintero,1 Claudia Mora-Karam,1 Julia Camacho-Osorio,1 Santiago Rhenals-Acuña,2 Francisco Arrieta-Acuña,2 Daniela Pérez-Mantilla,3 Nicolás Cristiano-Alvarado,4 Juan Pimentel1 1 Facultad de Medicina, Universidad…
Probability of hospitalization for chronic degenerative diseases in patients with COVID-19. Med Int Méx 2023; 39 (1): 39-45. https://doi.org/10.24245/mim.v39i1.7447 Enrique Villarreal-Ríos,1 María Guadalupe Ángeles-Correa,1 Liliana Galicia-Rodríguez,1 Gabriel Frontana-Vázquez,2 Emma Rosa Vargas-Daza,1 Sergio Javier Monroy-Amaro,3 Viridiana Ruiz-Pinal,3 Javier Dávalos-Álvarez,4 Shaid Santibáñez-Beltrán4…
Liver failure as a complication of SARS-CoV-2 infection. Med Int Méx 2023; 39 (1): 7-19. https://doi.org/10.24245/mim.v39i1.7119 Arely Estefanía Contreras-Pacheco,1 Julio César López-González,4 José Jaime Montelongo-Santiesteban,1 Yaeli Estefanía Valenzuela-Aldaba,2 Samantha Zermeño-Pacheco,2 Mayre Alejandra Sierra-Juárez,2 Manuel David Pérez-Ruiz,5 Luis Bernardo Enríquez-Sánchez3…